PME +12.39%: the medical software company jumped to all-time highs today on the back of a nice contract win. The $140m 10-year deal with Baylor Scott & White Health BSWH) is the company’s first in Texas where BSWH is the largest not-for-profit healthcare provider with around 500 radiologists.
PME has fallen 28.3% making it the worst performing stock on the ASX200 so far this year with the trouble all around valuation as opposed to business quality. While P/E’s are fairly irrelevant for these sorts of stocks, 110x 2022 earnings is a number to keep in one’s mind but probably more telling is their price to sales multiple P/S which sits 69x. We like...
Healthcare imaging company PME delivered a cracking full-year result yesterday sending the stock soaring over 15% to fresh all-time highs. Everything read well with revenue up almost 20% and NPAT rising over 33% to $30.9m, the company also announced a 8c dividend although with a yields close to that on offer at the bank this stocks clearly...
Imaging business PME has been a strong performer post COVID with its strong half-year result delivered in March confirming the business is kicking goals – revenue was up almost 8% to $31.6m while profit was just shy of $20m. We think PME is very likely to test $50 over the next 12-months but the risk / reward is only compelling under $40.
Pro Medicus (PME) is a billing, booking and software management company for medical corporations and practices. The software is available to hospitals, imaging groups and other health entities in Australia, North America and Europe.
Take a free 14 day Market Matters trial – full access to all our reports, portfolios, positions, buy and sell recommendations. Access the latest views on the latest developments from professional money managers. It's free and no payment details are required